Schmoll D: Difference between revisions
From Bioblast
No edit summary |
Beno Marija (talk | contribs) Β |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 3: | Line 3: | ||
|firstname=Dieter | |firstname=Dieter | ||
|title=Dr. | |title=Dr. | ||
|institution=Sanofi-Aventis Deutschland GmbH Β | |institution=Sanofi-Aventis Deutschland GmbH | ||
R&D | R&D DIAB Div. / Innovation&ext.Network. FF | ||
|address=Industriepark Hoechst Β | |address=Industriepark Hoechst Β | ||
Line 12: | Line 12: | ||
|city=Frankfurt am Main | |city=Frankfurt am Main | ||
|country=Germany | |country=Germany | ||
|mailaddress= | |mailaddress=Dieter.Schmoll@sanofi.com | ||
|weblink=www.sanofi.de | |||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at== | |||
::::* [[IOC54|IOC54 Schroecken AT]] |
Latest revision as of 16:45, 12 February 2018
Name | Schmoll Dieter, Dr. |
---|---|
Institution | Sanofi-Aventis Deutschland GmbH
R&D DIAB Div. / Innovation&ext.Network. FF |
Address | Industriepark Hoechst
Bldg. H825, Room 243, 65926 |
City | Frankfurt am Main |
State/Province | |
Country | Germany |
[email protected] | |
Weblink | www.sanofi.de |
O2k-Network Lab | DE Frankfurt Schmoll D |
Labels:
Publications
Published | Reference | |
---|---|---|
Karusheva 2019 Am J Clin Nutr | 2019 | Karusheva Y, Koessler T, Strassburger K, Markgraf D, Mastrototaro L, Jelenik T, Simon MC, Pesta D, Zaharia OP, BΓ³dis K, BΓ€renz F, Schmoll D, Wolkersdorfer M, Tura A, Pacini G, Burkart V, MΓΌssig K, Szendroedi J, Roden M (2019) Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial. Am J Clin Nutr 110:1098-107. |